Gonçalves, C.A.; Pereira-da-Silva, G.; Silveira, R.C.C.P.; Mayer, P.C.M.; Zilly, A.; Lopes-Júnior, L.C.
Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review. Cancers 2024, 16, 672.
https://doi.org/10.3390/cancers16030672
AMA Style
Gonçalves CA, Pereira-da-Silva G, Silveira RCCP, Mayer PCM, Zilly A, Lopes-Júnior LC.
Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review. Cancers. 2024; 16(3):672.
https://doi.org/10.3390/cancers16030672
Chicago/Turabian Style
Gonçalves, Caroline Amélia, Gabriela Pereira-da-Silva, Renata Cristina Campos Pereira Silveira, Paulo César Morales Mayer, Adriana Zilly, and LuÃs Carlos Lopes-Júnior.
2024. "Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review" Cancers 16, no. 3: 672.
https://doi.org/10.3390/cancers16030672
APA Style
Gonçalves, C. A., Pereira-da-Silva, G., Silveira, R. C. C. P., Mayer, P. C. M., Zilly, A., & Lopes-Júnior, L. C.
(2024). Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review. Cancers, 16(3), 672.
https://doi.org/10.3390/cancers16030672
